Spectral AI, Inc.

Spectral AI, Inc. (Nasdaq: MDAI) filed an 8-K with the Securities and Exchange Commission on September 7, 2023, disclosing a current reportable event following the company's de-SPAC business combination earlier that year. Spectral AI develops artificial-intelligence-driven wound assessment technology, with its core platform using multispectral imaging to evaluate burn wound depth and severity for clinical and military medical applications. The company entered public markets in 2023 through a SPAC merger, operating in the healthcare technology and medical devices sector, and the September filing reflects activity during its early post-combination period as a Nasdaq-listed reporting company. For complete filing history, sponsor details, and deal data on MDAI and hundreds of other SPAC transactions, sign up for full access at SpacDesk.